Skip to content

Clinical trials

Cholangiocarcinoma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Country / region: Japan Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20142
20151
20161
20173
20194
20204
20211
20221
20234
20243
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting6
Recruiting6
Terminated3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
AbbVie2
City of Hope Medical Center2
EMD Serono Research & Development Institute, Inc.2
Incyte Corporation2
Merck Sharp & Dohme LLC2
Taiho Oncology, Inc.2
Aichi Medical University1
Amgen1
Astellas Pharma Global Development, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma28
Gallbladder Neoplasms9
Ovarian Neoplasms6
Stomach Neoplasms6
Biliary Tract Neoplasms5
Carcinoma, Hepatocellular5
Carcinoma, Non-Small-Cell Lung5
Breast Neoplasms4
Colorectal Neoplasms4
Esophageal Neoplasms4

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.